SpliceBio Appoints Leading Ophthalmology Expert Aniz Girach as Chief Medical Officer

  • Dr. Girach is a world-renowned specialist in the field of ophthalmology and gene therapy
  • Appointment further strengthens SpliceBio’s leadership team as it accelerates lead program targeting Stargardt disease towards clinical development
  • Revolutionizing genetic medicine with its proprietary Protein Splicing platform

BARCELONA, January 3rd, 2024 – SpliceBio, a genetic medicines company harnessing Protein Splicing to develop the next generation of gene therapies, is pleased to announce the appointment of Aniz Girach, MD as Chief Medical Officer.

Read more…